Pharsight

UNIVERSITY OF WASHINGTON CENTER FOR COMMERCIALIZATION PATENTS FACING OPPOSITIONS

Top patents of UNIVERSITY OF WASHINGTON CENTER FOR COMMERCIALIZATION facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2838548B1 19 Jul, 2023 Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof Mar, 2033 1